These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

361 related items for PubMed ID: 30361909

  • 1. Ultrasound Risk Assessment Combined with Molecular Markers of Galectin-3, c-MET, HBME-1 and CK19 for Diagnosis of Malignant and Benign Thyroid Nodules.
    Han RL, Wang J, Zhang FJ, Zhao N, Gao BL.
    Pathol Oncol Res; 2019 Jul; 25(3):1075-1081. PubMed ID: 30361909
    [Abstract] [Full Text] [Related]

  • 2. Immunohistochemical expression of HBME-1 and galectin-3 in the differential diagnosis of follicular-derived thyroid nodules.
    Abd-El Raouf SM, Ibrahim TR.
    Pathol Res Pract; 2014 Dec; 210(12):971-8. PubMed ID: 25041837
    [Abstract] [Full Text] [Related]

  • 3. Diagnostic significance of CK19, RET, galectin-3 and HBME-1 expression for papillary thyroid carcinoma.
    Zhu X, Sun T, Lu H, Zhou X, Lu Y, Cai X, Zhu X.
    J Clin Pathol; 2010 Sep; 63(9):786-9. PubMed ID: 20644217
    [Abstract] [Full Text] [Related]

  • 4. Diagnostic value of galectin-3, HBME-1, cytokeratin 19, high molecular weight cytokeratin, cyclin D1 and p27(kip1) in the differential diagnosis of thyroid nodules.
    Park YJ, Kwak SH, Kim DC, Kim H, Choe G, Park DJ, Jang HC, Park SH, Cho BY, Park SY.
    J Korean Med Sci; 2007 Aug; 22(4):621-8. PubMed ID: 17728499
    [Abstract] [Full Text] [Related]

  • 5. [Usefulness of CK19, HBME-1 and galectin-3 expressions in differential diagnosis of thyroid papillary microcarcinoma from benign lesions].
    Tong J, Wang Y, Da JP.
    Zhonghua Zhong Liu Za Zhi; 2011 Aug; 33(8):599-604. PubMed ID: 22325220
    [Abstract] [Full Text] [Related]

  • 6. Differential diagnostic significance of HBME-1, CK19 and S100 in various thyroid lesions.
    Palo S, Biligi DS.
    Malays J Pathol; 2017 Apr; 39(1):55-67. PubMed ID: 28413206
    [Abstract] [Full Text] [Related]

  • 7. Role of cd56 and e-cadherin expression in the differential diagnosis of papillary thyroid carcinoma and suspected follicular-patterned lesions of the thyroid: the prognostic importance of e-cadherin.
    Ceyran AB, Şenol S, Şimşek BÇ, Sağıroğlu J, Aydın A.
    Int J Clin Exp Pathol; 2015 Apr; 8(4):3670-80. PubMed ID: 26097548
    [Abstract] [Full Text] [Related]

  • 8. Defining the value of CD56, CK19, Galectin 3 and HBME-1 in diagnosis of follicular cell derived lesions of thyroid with systematic review of literature.
    Dunđerović D, Lipkovski JM, Boričic I, Soldatović I, Božic V, Cvejić D, Tatić S.
    Diagn Pathol; 2015 Oct 26; 10():196. PubMed ID: 26503236
    [Abstract] [Full Text] [Related]

  • 9. Immunohistochemical diagnosis of papillary thyroid carcinoma.
    Cheung CC, Ezzat S, Freeman JL, Rosen IB, Asa SL.
    Mod Pathol; 2001 Apr 26; 14(4):338-42. PubMed ID: 11301350
    [Abstract] [Full Text] [Related]

  • 10. The Role of CD56 in Thyroid Fine Needle Aspiration Cytology: A Pilot Study Performed on Liquid Based Cytology.
    Bizzarro T, Martini M, Marrocco C, D'Amato D, Traini E, Lombardi CP, Pontecorvi A, Fadda G, Larocca LM, Rossi ED.
    PLoS One; 2015 Apr 26; 10(7):e0132939. PubMed ID: 26186733
    [Abstract] [Full Text] [Related]

  • 11. Utility of immunohistochemical markers in differentiating benign from malignant follicular-derived thyroid nodules.
    Saleh HA, Jin B, Barnwell J, Alzohaili O.
    Diagn Pathol; 2010 Jan 26; 5():9. PubMed ID: 20181018
    [Abstract] [Full Text] [Related]

  • 12. Combined staining for immunohistochemical markers in the diagnosis of papillary thyroid carcinoma: improvement in the sensitivity or specificity?
    Wu G, Wang J, Zhou Z, Li T, Tang F.
    J Int Med Res; 2013 Aug 26; 41(4):975-83. PubMed ID: 23857157
    [Abstract] [Full Text] [Related]

  • 13. [Application value of fine needle aspiration and cell block in preoperative diagnosis of thyroid cancer and discrimination of follicular tumor].
    Fang Q, Cai C, Chen H.
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 Aug 26; 50(8):668-72. PubMed ID: 26696207
    [Abstract] [Full Text] [Related]

  • 14. HBME-1 and CK19 are highly discriminatory in the cytological diagnosis of papillary thyroid carcinoma.
    Nga ME, Lim GS, Soh CH, Kumarasinghe MP.
    Diagn Cytopathol; 2008 Aug 26; 36(8):550-6. PubMed ID: 18618720
    [Abstract] [Full Text] [Related]

  • 15. [Expression of GADD153 in follicular tumors of thyroid and comparison with CK19, Galectin-3 and HBME-1].
    Tang QS, Teng XD, Ding W, Zhou J, Yao HT, Ying LX, Xu LM.
    Zhonghua Bing Li Xue Za Zhi; 2011 Nov 26; 40(11):745-8. PubMed ID: 22336157
    [Abstract] [Full Text] [Related]

  • 16. Diagnostic value of TROP-2 expression in papillary thyroid carcinoma and comparison with HBME-1, galectin-3 and cytokeratin 19.
    Murtezaoglu AR, Gucer H.
    Pol J Pathol; 2017 Nov 26; 68(1):1-10. PubMed ID: 28547974
    [Abstract] [Full Text] [Related]

  • 17. Challenge in the Pathological Diagnosis of the Follicular- Patterned Thyroid Lesions.
    Elsers DA, Hussein MRA, Osman MH, Mohamed GA, Hosny G.
    Asian Pac J Cancer Prev; 2021 Oct 01; 22(10):3365-3376. PubMed ID: 34711014
    [Abstract] [Full Text] [Related]

  • 18. [Expression of cytokeratin19, galectin-3 and HBME-1 in thyroid lesions and their differential diagnoses].
    Teng XD, Wang LJ, Yao HT, Li J, Ding W, Yan LP.
    Zhonghua Bing Li Xue Za Zhi; 2004 Jun 01; 33(3):212-6. PubMed ID: 15256110
    [Abstract] [Full Text] [Related]

  • 19. Diagnostic value of differential expression of CK19, Galectin-3, HBME-1, ERK, RET, and p16 in benign and malignant follicular-derived lesions of the thyroid: an immunohistochemical tissue microarray analysis.
    Barroeta JE, Baloch ZW, Lal P, Pasha TL, Zhang PJ, LiVolsi VA.
    Endocr Pathol; 2006 Jun 01; 17(3):225-34. PubMed ID: 17308359
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of the follicular patterned thyroid lesions based on the WHO 2022 criteria with an emphasis on the grey-zone lesions.
    Misra S, Dhawan S, Badwal S, Sengupta A, Khosla A, Agarwal SK, Rao S.
    Ann Diagn Pathol; 2024 Aug 01; 71():152282. PubMed ID: 38522359
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.